10.1002/ejoc.201800631
European Journal of Organic Chemistry
FULL PAPER
free of charge from: The Director, CCDC, 12 Union Road, Cambridge, CB2
1EZ, UK. Fax: +44(1223)336-033, e-mail:deposit@ccdc.cam.ac.uk, or
Diethyl
((1R,2S)-2-(dibenzylamino)-1-fluoro-3-
phenylpropyl)phosphonate (14d); Colorless oil (272 mg, 58 %): 1H NMR
(600 MHz, CDCl3) δ = 7.25 (ddt, J = 4.6, 3.2, 2.0 Hz, 4H, ArH), 7.14 (dd, J
= 4.9, 1.8 Hz, 5H, ArH), 7.09 – 7.05 (m, 2H, ArH), 7.00 (dd, J = 6.7, 2.9 Hz,
4H, ArH), 5.34 (dd, J = 47.2, 8.8 Hz, 1H, CHFP), 4.23 – 4.16 (m, 2H,
OCH2CH3), 4.14 – 4.08 (m, 1H, OCHHCH3), 4.06 – 4.00 (m, 1H,
OCHHCH3), 3.96 (d, J = 14.1 Hz, 2H, PhCHHN), 3.45 (dddd, J = 35.2, 11.4,
5.6, 3.2 Hz, 1H, PhCHHCHN), 3.36 (dd, J = 14.2, 1.7 Hz, 2H, PhCHHN),
3.24 (dd, J = 14.7, 3.1 Hz, 1H, PhCHHCHN), 3.01 (dd, J = 14.7, 11.3 Hz,
1H, PhCHHCHN), 1.32 (t, J = 7.1 Hz, 3H, OCH2CH3), 1.24 (t, J = 7.1 Hz,
3H, OCH2CH3). 13C NMR (151 MHz, CDCl3) δ = 139.47, 138.82, 129.66,
128.55, 127.99, 127.88, 126.74, 125.87 (8 x s, Ar), 87.26 (dd, J = 186.6,
165.3 Hz, CHFP), 63.12 (d, J = 6.8 Hz, OCH2CH3), 62.71 (d, J = 6.9 Hz,
OCH2CH3), 58.72 (dd, J = 18.5, 5.6 Hz, PhCH2CH), 53.78 (s, 2 x PhCH2N),
32.21 (d, J = 7.2 Hz, PhCH2), 16.41 (d, J = 5.6 Hz, OCH2CH3), 16.34 (d, J
= 5.6 Hz, OCH2CH3). 19F NMR (565 MHz, CDCl3) δ = -220.25 (ddd, J =
82.7, 47.2, 35.3 Hz). 19F{/1H} NMR (565 MHz, CDCl3) δ = -220.24 (d, J =
82.2 Hz). 31P{/1H} NMR (243 MHz, CDCl3) δ = 17.31 (d, J = 82.2 Hz). IR
(ATR): 3060.48, 3027.69, 2982.37, 2932.23, 2910.06, 2831.95, 2801.1,
1601.59, 1493.6, 1452.14, 1389.46, 1368.25, 1256.4, 1120.44, 1022.09,
970.98, 742.46, 698.10, 566.00 cm-1. HRMS (ESI) calcd for C27H34FNO3P
([M+H]+): 470.2260, found: 470.2253.
Experimental Details.
Compounds 12a-i were prepared according to previously reported
procedures. Isolated yield of 12a-i from 11a-i: 12a (94 %), 12b (75 %), 12c
(85 %), 12d (89 %), 12e (89 %), 12f (80 %), 12g (72 %), 12h (75 %), 12i
(80 %). The NMR data were in good agreement.[19-23, 37]
Compounds 13a-i were prepared according to previously reported
procedure. The NMR data for 13a-b, 13d-h were in good agreement.[19, 25]
Racemic mixture of diethyl ((1R,2S)-2-(1,3-dioxoisoindolin-2-yl)-1-
hydroxy-3-phenylpropyl)phosphonate (13c): White solid (1160 mg,
72%): 1H NMR (400 MHz, CDCl3) δ = 7.73 (dt, J = 7.5, 3.7 Hz, 2H, ArH),
7.65 (dd, J = 5.5, 3.1 Hz, 2H, ArH), 7.18 – 7.03 (m, 5H, ArH), 5.07 (dd, J =
8.9, 5.0 Hz, 1H, OH), 4.84 (dtd, J = 11.6, 7.9, 7.5, 3.8 Hz, 1H, CHCH2Ph),
4.80 – 4.70 (m, 1H, CHP), 4.25 – 4.10 (m, 2H, OCH2CH3), 4.10 – 3.96 (m,
2H, OCH2CH3), 3.57 (dd, J = 14.1, 3.8 Hz, 1H, CHHPh), 3.36 (dd, J = 14.1,
11.7 Hz, 1H, CHHPh), 1.24 (t, J = 7.1 Hz, 3H, OCH2CH3), 1.05 (t, J = 7.1
Hz, 3H, OCH2CH3). 13C NMR (101 MHz, CDCl3) δ = 167.92 (s, C=O),
137.61 (d, J = 1.7 Hz), 133.78, 131.62, 129.00, 128.27, 126.38, 123.09 (7
x Ar), 67.85 (d, J = 161.6 Hz, CHP), 63.08 (d, J = 7.2 Hz, OCH2CH3), 62.97
(d, J = 7.1 Hz, OCH2CH3), 53.19 (d, J = 1.6 Hz, CHCH2Ph), 34.68 (d, J =
10.1 Hz, CH2Ph), 16.21 (d, J = 5.6 Hz, OCH2CH3), 15.93 (d, J = 6.3 Hz,
OCH2CH3). 31P{/1H} NMR (162 MHz, CDCl3) δ = 22.50 (s). HRMS (ESI)
calcd for C21H25NO6P ([M+H]+): 418.1419, found: 418.1412.
Diethyl
((1S,2R)-2-(dibenzylamino)-1-fluoro-3-
phenylpropyl)phosphonate (14e); Colorless oil (282 mg, 60 %): 1H NMR
(600 MHz, CDCl3) δ = 7.33 (m, 1H, ArH), 7.26 (m, 2H, ArH), 7.20 – 7.12
(m, 6H, ArH), 7.07 (dd, J = 6.5, 2.9 Hz, 2H, ArH), 7.04 – 6.96 (m, 4H, ArH),
5.34 (dd, J = 47.2, 8.8 Hz, 1H, CHFP), 4.27 – 4.17 (m, 2H, OCH2CH3),
4.13 (m, 1H, OCHHCH3), 4.04 (m, 1H, OCHHCH3), 3.97 (d, J = 14.2 Hz,
2H, PhCHHN), 3.45 (dddd, J = 35.2, 11.4, 5.6, 3.2 Hz, 1H, PhCHHCHN),
3.36 (dd, J = 14.2, 1.8 Hz, 2H, PhCHHN), 3.24 (dd, J = 14.7, 3.1 Hz, 1H,
PhCHHCHN), 3.01 (dd, J = 14.7, 11.3 Hz, 1H, PhCHHCHN), 1.33 (t, J =
7.1 Hz, 3H, OCH2CH3), 1.25 (t, J = 7.1 Hz, 3H, OCH2CH3). 13C NMR (151
MHz, CDCl3) δ = 139.51, 138.85, 129.69, 128.59, 128.02, 127.91, 126.77,
125.90 (8 x s, Ar), 87.30 (dd, J = 186.7, 165.3 Hz, CHFP), 63.15 (d, J =
6.7 Hz, OCH2CH3), 62.75 (d, J = 6.7 Hz, OCH2CH3), 58.76 (dd, J = 18.5,
5.7 Hz, PhCH2CH), 53.82 (s, 2 x PhCH2N), 32.24 (d, J = 7.3 Hz, PhCH2),
16.44 (d, J = 5.6 Hz, OCH2CH3), 16.38 (d, J = 5.5 Hz, OCH2CH3). 19F NMR
(565 MHz, CDCl3) δ = -220.26 (ddd, J = 82.2, 47.2, 35.3 Hz). 19F{/1H} NMR
(565 MHz, CDCl3) δ = -220.25 (d, J = 82.2 Hz). 31P{/1H} NMR (243 MHz,
CDCl3) δ = 17.27 (d, J = 83.1 Hz). IR (ATR): 3060.48, 3026.73, 2981.41,
2930.31, 2911.99, 2831.95, 2800.13, 1601.59, 1493.6, 1452.14, 1389.46,
1368.25, 1256.4, 1120.44, 1024.02, 970.98, 743.42, 699.07 cm-1. HRMS
(ESI) calcd for C27H34FNO3P ([M+H]+): 470.2260, found: 470.2256.
Diethyl
((1R,2S)-2-(dibenzylamino)-1-hydroxy-3-
methylpentyl)phosphonate (13i); Colorless oil (634 mg, 32%): 1H NMR
(600 MHz, CDCl3) δ = 7.34 (d, J = 6.7 Hz, 4H, ArH), 7.30 (t, J = 7.6 Hz,
4H, ArH), 7.26 – 7.20 (m, 2H, ArH), 4.26 – 4.01 (m, 5H, 2 x OCH2CH3,
CHP), 3.80 (s, 4H, 2 x CH2Ph), 3.03 (dd, J = 8.3, 3.6 Hz, 1H, OH), 2.91
(ddd, J = 23.2, 9.5, 4.0 Hz, 1H, CHCH(CH3)CH2CH3), 2.16 (dddq, J = 12.8,
9.4, 6.4, 3.3 Hz, 1H, CH(CH3)CH2CH3), 2.00 (dtt, J = 15.0, 7.5, 3.7 Hz, 1H,
CHHCH3), 1.34 (td, J = 7.1, 1.0 Hz, 3H, OCH2CH3), 1.30 – 1.24 (m, 4H,
OCH2CH3, CHHCH3), 0.95 (d, J = 6.5 Hz, 3H, CH(CH3)), 0.91 (t, J = 7.4
Hz, 3H, CH2CH3). 13C NMR (151 MHz, CDCl3) δ = 139.64, 129.44, 128.22,
127.05 (4 x s, Ar), 66.63 (d, J = 153.4 Hz, CHP), 64.12 (d, J = 4.0 Hz,
CHCH(CH3)CH2CH3), 62.52 (d, J = 7.1 Hz, OCH2CH3), 62.11 (d, J = 7.3
Hz, OCH2CH3), 55.09 (s, CH2Ph), 33.91 (s, CH(CH3)CH2CH3), 27.22 (s,
CHHCH3), 16.75 (s, CH(CH3)), 16.43 (d, J = 5.9 Hz, OCH2CH3), 16.39 (d,
J = 5.9 Hz, OCH2CH3), 11.21 (s, CH2CH3). 31P NMR (243 MHz, CDCl3) δ
= major diastereoisomer 24.86 (s), minor diastereoisomer 23.44 (s).
HRMS (ESI) calcd for C24H37NO4P ([M+H]+): 434.2460, found: 434.2453.
Diethyl ((1R,2S)-2-(dibenzylamino)-1-fluoropropyl)phosphonate (14f);
Colorless oil (165 mg, 42 %): 1H NMR (600 MHz, CDCl3) δ = 7.41 – 7.17
(m, 10H, ArH), 5.14 (ddd, J = 47.3, 7.6, 1.5 Hz, 1H, CHFP), 4.15 – 4.07
(m, 2H, OCH2CH3), 4.07 – 3.88 (m, 2H, OCH2CH3), 3.70 (d, J = 14.0 Hz,
2H, PhCHHN), 3.60 (d, J = 14.0 Hz, 2H, PhCHHN), 3.36 – 3.24 (m, 1H,
CH3CH), 1.32 (dd, J = 7.1, 1.9 Hz, 3H, CH3), 1.26 (t, J = 7.1 Hz, 3H,
OCH2CH3), 1.18 (t, J = 7.1 Hz, 3H, OCH2CH3). 13C NMR (151 MHz, CDCl3)
δ = 139.63, 128.59, 128.18, 126.90 (4 x s, Ar), 90.78 (dd, J = 185.4, 166.2
Hz, CHFP), 63.02 (d, J = 6.7 Hz, OCH2CH3), 62.49 (d, J = 6.7 Hz,
OCH2CH3), 54.19 (s, PhCH2), 54.17 (s, PhCH2), 52.71 (dd, J = 19.3, 6.5
Hz, CH3CH), 16.34 (d, J = 5.6 Hz, OCH2CH3), 16.24 (d, J = 5.9 Hz,
OCH2CH3), 9.73 (d, J = 7.8 Hz, CH3). 19F NMR (565 MHz, CDCl3) δ = -
220.51 (ddd, J = 81.6, 47.3, 32.6 Hz). 19F NMR (565 MHz, CDCl3) δ = -
220.51 (d, J = 83.1 Hz). 31P{/1H} NMR (243 MHz, CDCl3) δ = 16.88 (d, J =
82.3 Hz). IR (ATR): 3061.44, 3028.66, 2983.34, 2932.23, 2803.99, 1493.6,
General procedures for deoxyfluorination.
General
procedure
for
deoxyfluorination
of
α-hydroxy-β-
aminophosphonates 13a-d,h with DAST,[19a] DeoxoFluor,[38] DAST or
DeoxoFluor / TMS-morph,[26a], XtalFluor-E / 3HF·Et3N or 2HF·Et3N or
DBU,[28] Fluolead.[16]
PyFluor (1,2 mmol) and DBU (2 mmol) were added to a stirred solution of
amino alcohol 13 (1mmol) in 2,5 mL PhMe, under an argon atmosphere.
The mixture was stirred at room temperature for 18h. The reaction mixture
was then diluted with 20 mL of water and extracted with AcOEt (3 x 15 mL).
The organic layers were dried over MgSO4 or Na2SO4, filtrated and
concentrated under reduced pressure. The crude products were isolated
using column chromatography (n-hexane/ethyl acetate 10:90, v/v → n-
hexane/ethyl acetate 40:60, v/v).
1451.17, 1368.25, 1256.4, 1160.94, 1021.12, 970.02, 742.46, 698.10 cm-
1
.
HRMS (ESI) calcd for C21H30FNO3P ([M+H]+): 394.1947, found:
394.1941.
This article is protected by copyright. All rights reserved.